Order results by:
Issue | Title | |
Vol 18, No 2 (2025) | Analysis of fatty acid profiles of micronutrients and pharmaceuticals based on omega-3 polyunsaturated fatty acid extracts from natural sources | Abstract similar documents |
I. Yu. Torshin, O. A. Gromova, A. A. Garanin | ||
"... Background. Omega-3 polyunsaturated fatty acids (ω3-PUFA) are an important factor in somatic ..." | ||
Vol 15, No 2 (2022) | Biophysical modeling indicates a high affinity of ethyl esters of omega-3 polyunsaturated fatty acids to the enzymes of the pro-inflammatory arachidonic acid cascade | Abstract similar documents |
I. Yu. Torshin, O. A. Gromova | ||
"... Background. Omega-3 polyunsaturated fatty acids (ω-3 PUFAs) are widely used in modern cardiology ..." | ||
Vol 12, No 2 (2019) | Concerning the “repression” of ω -3 polyunsaturated fatty acids by adepts of evidence-based medicine | Abstract similar documents |
I. Yu. Torshin, O. A. Gromova, Zh. D. Kobalava | ||
"... that ω -3 polyunsaturated fatty acids (PUFAs) are not effective either for the prevention ..." | ||
Vol 16, No 1 (2023) | Modern biomarkers of acute kidney injury | Abstract similar documents |
D. I. Korabelnikov, M. O. Magomedaliev | ||
"... -microglobulin, kidney injury molecule-1, fatty acid binding protein) over the conventional glomerular filtration ..." | ||
Vol 8, No 3 (2015) | NON-ALCOHOLIC FATTY LIVER DISEASE OUTCOMES FUNNEL | Abstract similar documents |
D. V. Blinov | ||
"... Introduction. Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized as an important ..." | ||
Vol 16, No 3 (2023) | An open-label, controlled trial of the clinical effects of Laennec® in patients with nonalcoholic steatohepatitis or cirrhosis | Abstract similar documents |
M. Imawari, M. Nagase, I. Yu. Torshin, O. A. Gromova | ||
"... ® in the treatment of nonalcoholic fatty liver disease (NAFLD) in a clinical trial. Material and methods. The study ..." | ||
Vol 9, No 4 (2016) | PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN REPUBLIC OF BASHKORTOSTAN (REGIONAL RESULTS OF DIREG 2 STUDY) | Abstract similar documents |
D. Kh. Kalimullina, A. S. Yurkina, T. I. Ushakova, D. V. Blinov | ||
"... Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized as an important problem ..." | ||
Vol 10, No 1 (2017) | THE PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN OUTPATIENTS IN THE FAR EAST FEDERAL DISTRICT | Abstract similar documents |
V. A. Nevzorova, M. V. Mokshina, T. A. Brodskaya, D. A. Vasil’chenkov, D. V. Blinov, T. I. Ushakova | ||
"... , stimulates medical experts to closely study the epidemiology of non-alcoholic fatty liver disease (NAFLD ..." | ||
Vol 17, No 4 (2024) | Study of the effect of human placenta hydrolysate in a new model of metabolic-associated fatty liver disease with iron overload | Abstract similar documents |
T. E. Bogacheva, O. A. Gromova, I. Yu. Torshin, V. I. Demidov, A. G. Kalacheva, A. A. Garanin, I. V. Gogoleva, L. E. Fedotova, O. A. Limanova, А. N. Mnatsakanyan, N. Yu. Zhidomorov, T. R. Grishina | ||
"... Background. The combination of metabolic-associated fatty liver disease (МAFLD) with iron overload ..." | ||
Vol 8, No 1 (2015) | PHARMACOECONOMIC ANALYSIS OF EVEROLIMUS IMMUNOSUPRESSIVE THERAPY AFTER RENAL TRANSPLANTATION | Abstract similar documents |
M. V. Avxentyeva, N. A. Avxentyev, M. Yu. Frolov, E. V. Derkach | ||
"... renal transplantation: everolimus plus reducedexposure cyclosporine and mycophenolic acid plus standard ..." | ||
Vol 9, No 2 (2016) | EPIDEMIOLOGICAL FEATURES OF NON-ALCOHOLIC FATTY LIVER DISEASE IN NOVOSIBIRSK (SIBERIAN FEDERAL DISTRICT): REGIONAL DATA OF OPEN MULTICENTER PROSPECTIVE STUDY DIREG 2 | Abstract similar documents |
V. V. Tsukanov, A. S. Yurkina, T. A. Ushakova, D. V. Blinov | ||
"... Non-alcoholic fatty liver disease (NAFLD) is an important medical and social problem. Essentially ..." | ||
Vol 16, No 3 (2023) | The role of ferritin in liver disease assessment | Abstract similar documents |
V. G. Radchenko, V. B. Grinevich, E. S. Ivanyuk, L. B. Lazebnik | ||
"... of patients with nonalcoholic fatty liver disease (NAFLD), manifestations of hyperferritinemia are revealed ..." | ||
Vol 15, No 2 (2022) | Clinical study of real-time polymerase chain reaction test kit for SARS-CoV-2 ribonucleic acids detection | Abstract similar documents |
M. Yu. Dmitryukova, A. A. Golod, M. E. Senina, A. E. Gushchin | ||
"... ) test kit for SARS-CoV-2 ribonucleic acids (RNA) qualitative detection adapted for using with automated ..." | ||
Vol 14, No 2 (2021) | Systematic computer analysis of published literature on nutritional support for vaccination | Abstract similar documents |
A. G. Chuchalin, I. Yu. Torshin, O. A. Gromova | ||
"... , and omega-3 polyunsaturated fatty acid support the functioning of T and B-lymphocytes (energy metabolism ..." | ||
Vol 17, No 1 (2024) | Chemoreactome screening of aquacobalamin and heptamethyl ester of cyanoaquacobyrinic acid cytotoxic effects on tumor cells with experimental confirmation on BT-474 and A549 cell | Abstract similar documents |
I. Yu. Torshin, M. V. Filimonova, O. A. Gromova, L. A. Maiorova, M. A. Sorokina, D. E. Frolova, A. N. Gromov, I. A. Reyer | ||
"... and heptamethyl ester of cyanoaquacobyrinic acid (HECСA). Material and methods. Chemoreactome screening ..." | ||
Vol 7, No 1 (2014) | PATIENTS WITH NEUROLOGICAL DISEASES: RATIONALE FOR PHARMACOECONOMIC EVALUATION OF COST OPTIMIZATION FOR MANAGEMENT WITH NEURON-SPECIFIC PROTEINS ASSESSMENT AS MARKERS OF INCREASED BLOOD-BRAIN-BARRIER PERMEABILITY | Abstract similar documents |
D. V. Blinov | ||
"... neuronspecific enolase (NSE) and glial fibrillary acid protein (GFAP) concentration over a 6-month period ..." | ||
Vol 18, No 1 (2025) | Problems of using phenol (hydroxybenzene) and parabens as pharmaceutical stabilizers: analysis using machine learning methods | Abstract similar documents |
I. Yu. Torshin, O. A. Gromova | ||
"... (metabolic disorders in a pregnant woman, including the metabolism of purines and fatty acids beta-oxidation ..." | ||
Vol 15, No 4 (2022) | Pharmacoeconomic analysis of antithrombotic therapy in patients with acute coronary syndrome and patients with atrial fibrillation who underwent percutaneous coronary intervention | Abstract similar documents |
V. А. Ryagina, К. I. Matrenin, D. G. Shchurov, Т. S. Teptsova | ||
"... with acetylsalicylic acid (ASA) in comparison with clopidogrel in combination with ASA in patients with acute coronary ..." | ||
Vol 8, No 1 (2015) | PHARMACOEPIDEMIOLOGICAL EVALUATION OF HEPATOTROPIC THERAPY IN REAL CLINICAL PRACTICE | Abstract similar documents |
D. V. Blinov, U. V. Zimovina, T. I. Ushakova | ||
"... countries. Non-alcoholic fatty liver disease (NAFLD) is a major cause of chronic liver diseases. Alcoholic ..." | ||
Vol 18, No 1 (2025) | Amelioration of histopathological damage in mice with induced hyperlipidemia by terpenes and phytosterols extracted from Iraqi chickpea | Abstract PDF (Eng) similar documents |
N. R. Hwerif, A. R. Abu Raghif, E. J. Kadhim | ||
"... a marked and diffused cytoplasmic fatty infiltration of hepatic and cardiac cells. These effects were ..." | ||
Vol 9, No 3 (2016) | METHOD «COST-EFFECTIVENESS» IN EVALUETION OF ATIBIOTIC TREATMENT OF ACYTR OBSTRUCTIVE BRONCHITIS IN CHILDREN IN HOSPITAL | Abstract similar documents |
O. V. Zhukova, S. V. Kononova | ||
"... / clavulanic acid). The effectiveness of Augmentin (0.591) and Amoxiclav (0.530) was comparable. The Augmentin ..." | ||
Vol 18, No 1 (2025) | The sale of medicines used for diabetes mellitus treatment in retail segment of Russian pharmaceutical market | Abstract similar documents |
I. K. Petrukhina, A. M. Lazarev, T. K. Ryazanova, P. A. Lebedev, E. P. Gladunova, G. T. Glembotskaya | ||
"... groups were studied: A10A, A10B, H04AA and A16AX (thioctic acid), as well as “sibutramine + metformin ..." | ||
Online First | Osteoarthritis therapy misconcepts | Abstract similar documents |
O. A. Shavlovskaya, О. А. Gromova, I. Yu. Torshin, I. D. Romanov | ||
"... ), glucosamine sulfate (GS), diacerein, avocado soybean unsaponifiables, hyaluronic acid (HA) for intra-articular ..." | ||
Vol 13, No 3 (2020) | Chemomicrobiomic analysis of glucosamine sulfate, prebiotics and non-steroidal anti-inflammatory drugs | Abstract similar documents |
O. A. Gromova, I. Yu. Torshin, A. V. Naumov, V. A. Maksimov | ||
"... of glucosamine sulfate (GS), diclofenac, acetylsalicylic acid (ASA), and three prebiotics (lactose, lactulose ..." | ||
Vol 14, No 4 (2021) | Analysis of the consumption volumes of antithrombotic drugs used for pharmacotherapy of atrial fibrillation in Saratov Region | Abstract similar documents |
А. V. Sokolov, О. V. Reshet’ko | ||
"... .53 NDDD per 1000 AF patients per day. Acetylsalicylic acid was included in the group of drugs accounting ..." | ||
Vol 16, No 2 (2023) | From misconceptions to reasonable osteoarthritis patients therapy | Abstract similar documents |
O. A. Shavlovskaya, О. А. Gromova, I. Yu. Torshin, I. D. Romanov | ||
"... unsaponifiables, hyaluronic acid (HA) for intra-articular administering. Only CS and GS have proven effectiveness ..." | ||
Vol 16, No 4 (2023) | Oncoprotective effects of chondroprotectors: glucosamine, chondroitin sulfate and undenatured type II collagen | Abstract similar documents |
I. Yu. Torshin, A. G. Chuchalin, O. A. Gromova | ||
"... -glycosylation of intracellular proteins, GS inhibits the pro-inflammatory effects of arachidonic acid cascade ..." | ||
Online First | Antitumor effects of vitamin B12 in vitro, in vivo, in silico | Abstract similar documents |
O. A. Gromova, D. E. Frolova, I. Yu. Torshin, M. V. Filimonova, M. A. Sorokina, I. A. Reyer, O. A. Limanova, L. E. Fedotova, L. A. Maiorova | ||
"... (heptamethyl cyanoquacobyric acid ester) significantly reduces the survival of tumor lines. BT-474 and A549 ..." | ||
Vol 18, No 2 (2025) | Current approaches to the treatment of vulvovaginal atrophy in women with gynecological and breast cancer | Abstract similar documents |
O. S. Gridasova, A. G. Solopova, E. I. Rumyantseva, A. E. Ivanov, D. О. Utkin, J. Kh. Khizroeva | ||
"... of life. In this patient population, hyaluronic acid combined with vitamins A and E has demonstrated ..." | ||
Vol 14, No 1 (2021) | Differences in the standardization of medicinal products based on extracts of chondroitin sulfate | Abstract similar documents |
O. A. Gromova, I. Yu. Torshin, B. Ts. Zaychik, E. V. Shikh, A. O. Ruzhitskiy, A. N. Galustyan, I. S. Sardaryan, I. V. Sarvilina | ||
"... with bicincholic acid was used. Chromatographic profiles of the studied CS extracts were measured to estimate ..." | ||
1 - 30 of 30 Items |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)